-
recombinant DNA-produced
analogue of the
human enzyme β-glucocerebrosidase.
Cerezyme is a freeze-dried
medicine containing imiglucerase,
manufactured by Genzyme...
-
manufacturer Omni Res srl. In 1994,
Genzyme received FDA
approval to
market Cerezyme, a
genetically engineered replacement for Ceredase. The
company acquired...
-
Cerezyme), Genzyme's
flagship treatment for Gaucher's disease. In 2014, the
annual cost of
eliglustat taken orally twice a day was $310,250.
Cerezyme...
- 2005
interview for The Wall
Street Journal that in 1991 one
treatment of
Cerezyme for one
patient took 22,000
placentas annually to manufacture, a difficult...
- a
difficult and
expensive procedure. A new
version of Ceredase,
called Cerezyme,
Imiglucerase which Genzyme produced in 1994
using genetically modified...
- 000 for a year of treatment,
while the
enzyme replacement therapy drug
Cerezyme costs $200,000 per year, and must be
taken by Gaucher's
disease patients...
-
Recombinant glucocerebrosidases used as
drugs include:
Imiglucerase (
Cerezyme)
Velaglucerase (Vpriv)
Taliglucerase alfa (Elelyso)
Closely related enzymes...
- was
approved by the FDA in
April 1991. An
improved drug,
imiglucerase (
Cerezyme), was
approved by the FDA in May 1994 and has
replaced the use of Ceredase...
- type 1
gaucher disease.
Ceredase (Alglucerase), for Gaucher's disease.
Cerezyme (Imiglucerase), for Gaucher's disease.
Elaprase (Idursulfase), marketed...
-
Ceporacin Ceptaz Ceradon Cerebyx Ceredase (Genzyme Corporation)
Ceretec Cerezyme (Genzyme Corporation)
cericlamine (INN)
cerivastatin (INN) Cernevit-12...
